Rujul Parikh, MD retweetledi

Hi #ASH24! This #OpenAccess review by @RujulParikh and @SagarLonialMD covers recent development of CAR T-cell therapies in myeloma, toxicities and limitations of CAR T-cell therapies, and strategies to overcome therapeutic challenges of multiple myeloma.
🔗acsjournals.onlinelibrary.wiley.com/doi/10.3322/ca…

English















